HAEVN Trademark

Trademark Overview


On Monday, January 27, 2025, a trademark application was filed for HAEVN with the United States Patent and Trademark Office. The USPTO has given the HAEVN trademark a serial number of 99020243. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, August 6, 2025. This trademark is owned by Ionis Pharmaceuticals, Inc.. The HAEVN trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing healthcare information, medical information, and pharmaceutical information online, by telephone, and through distribution of printed healthcare materials to healthcare providers, patients, physicians, medical office staff, pharmaceutical prescribers, caregivers, and pharmacies regarding patient access to and reimbursement for pharmaceuticals and safe and appropriate use and distribution of pharmaceuticals; providing healthcare information; medical information services; providing a website featuring medical information in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders; medical consulting services in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare...
haevn

General Information


Serial Number99020243
Word MarkHAEVN
Filing DateMonday, January 27, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, August 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding healthcare information, medical information, and pharmaceutical information online, by telephone, and through distribution of printed healthcare materials to healthcare providers, patients, physicians, medical office staff, pharmaceutical prescribers, caregivers, and pharmacies regarding patient access to and reimbursement for pharmaceuticals and safe and appropriate use and distribution of pharmaceuticals; providing healthcare information; medical information services; providing a website featuring medical information in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders; medical consulting services in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders; healthcare services, namely, providing an online database comprised of medical and healthcare information in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune lymphoproliferative, asthma, and rare diseases and disorders, and collecting data and information on hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 28, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIonis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010

Trademark Events


Event DateEvent Description
Monday, January 27, 2025NEW APPLICATION ENTERED
Monday, January 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 27, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, May 7, 2025ASSIGNED TO EXAMINER
Monday, May 5, 2025ASSIGNED TO EXAMINER
Thursday, May 15, 2025NON-FINAL ACTION WRITTEN
Tuesday, July 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 15, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 16, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 6, 2025SUSPENSION LETTER WRITTEN
Wednesday, August 6, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 6, 2025LETTER OF SUSPENSION E-MAILED
Thursday, May 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 15, 2025NON-FINAL ACTION E-MAILED